CD, I’ve spoke on the China factor here on this forum myself. Can’t imagine their being such a thing as a secret there. If a party official asks you a question, you answer it, in my opinion. That is why I was very excited to see HL double down and triple down on RVX. I will be curious to see if the data collected from patients in China matches up with data from patients from other parts of Europe. I couldn’t image that I’m the only investor that would want to get their hands on that information ASAP once a positive topline is released. If there is any indication of a thumb being on the scale there to tip the balance of data, then that could wipe the smile off of all of our faces, unless we have already cashed in that is. Just something to keep in mind in my opinion.

Regards 

DND